EPO and polycythemia: Lastly, the application of some exclusion criteria, including malignancy (which can trigger erythropoietin release) and drug use (especially steroids can stimulate erythrocytosis), may have led to a reduction in the number of patients with SP, but if this had not been performed, it would have created other limitations for the study, such as ignoring some factors that affect the levels of inflammation markers.